Vicriviroc

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameVicriviroc
Drug Alias NameVicrivirocum维利韦洛维立韦罗ScheringDSch-417690 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus internalization inhibitorsC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsColorectal NeoplasmsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme LLC
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsColorectal Neoplasms
Inactive IndicationsAcquired Immunodeficiency SyndromeHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG